Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
60
ALTS Quote, Financials, Valuation and Earnings
Last price:
$6.68
Seasonality move
:
4.92%
Day range:
$6.50 - $6.90
52-week range:
$1.29 - $7.75
Dividend yield:
0%
P/E ratio:
0.14x
P/S ratio:
--
P/B ratio:
8.86x
Volume:
132.5K
Avg. volume:
161.1K
1-year change:
100.59%
Market cap:
$118.7M
Revenue:
$12.5M
EPS (TTM):
-$0.49
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, ALT5 Sigma has -- downside to fair value with a price target of -- per share.
ALTS vs. S&P 500
-
Over the past 5 trading days, ALT5 Sigma has overperformed the S&P 500 by 0.28% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
ALT5 Sigma does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ALT5 Sigma has grown year-over-year revenues for 1 quarter straight. In the most recent quarter ALT5 Sigma reported revenues of $5.5M.
Earnings Growth
-
ALT5 Sigma has grown year-over-year earnings for 1 quarter straight. In the most recent quarter ALT5 Sigma reported earnings per share of -$0.18.
Enterprise value:
127.6M
EV / Invested capital:
0.00x
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
71.79x
Price / Operating cash flow:
40.20x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$8.9M
Return On Assets:
-10.57%
Net Income Margin (TTM):
-38.58%
Return On Equity:
-35.86%
Return On Invested Capital:
-23.43%
Operating Margin:
-39.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | $18M | -- | $5.5M | |
| Gross Profit | -- | -- | $8.9M | -- | $2.6M | |
| Operating Income | -$3.6M | -$5.5M | -$7.9M | -$1.8M | -$2.2M | |
| EBITDA | -$3.2M | -$3.7M | -$4.7M | -$1.2M | -$921K | |
| Diluted EPS | $5.98 | -$5.02 | -$0.49 | -$0.34 | -$0.18 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $10.5M | $9.6M | $637K | $1.2M | $31.8M | |
| Total Assets | $27.3M | $16.5M | $35M | $18.6M | $78M | |
| Current Liabilities | $17.5M | $20.6M | $3.5M | $8.1M | $38.2M | |
| Total Liabilities | $18.8M | $24M | $21.4M | $14.8M | $52.7M | |
| Total Equity | $8.5M | -$7.5M | $13.6M | $3.8M | $25.3M | |
| Total Debt | $1.2M | $2.6M | $69K | $2.9M | $14.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.7M | -$1.5M | $778K | -$544K | -$1.5M | |
| Cash From Investing | -$1.5M | $1K | $5.9M | -- | -- | |
| Cash From Financing | $2.2M | $1.2M | $7M | $600K | $1.5M | |
| Free Cash Flow | -$2.7M | -$1.5M | $778K | -$544K | -$1.5M | |
ALTS
Sector
Market Cap
$118.7M
$34.2M
Price % of 52-Week High
87.74%
43.73%
Dividend Yield
0%
0%
Shareholder Yield
-4.71%
-0.66%
1-Year Price Total Return
100.59%
-41.71%
Beta (5-Year)
2.150
0.657
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$6.44
200-day SMA
Buy
Level
$3.87
Bollinger Bands (100)
Buy
Level
4.51 - 6.31
Chaikin Money Flow
Sell
Level
-175.4M
20-day SMA
Buy
Level
$6.07
Relative Strength Index (RSI14)
Buy
Level
64.11
ADX Line
Buy
Level
31.69
Williams %R
Sell
Level
-18.5481
50-day SMA
Buy
Level
$5.09
MACD (12, 26)
Buy
Level
0.43
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
357.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.4014)
Sell
CA Score
(Annual)
Level (-2.6152)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (3.6805)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
Stock Forecast FAQ
In the current month, ALTS has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALTS average analyst price target in the past 3 months is --.
-
Where Will ALT5 Sigma Stock Be In 1 Year?
According to analysts, the consensus estimate is that ALT5 Sigma share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About ALT5 Sigma?
Analysts are divided on their view about ALT5 Sigma share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that ALT5 Sigma is a Sell and believe this share price will rise from its current level to --.
-
What Is ALT5 Sigma's Price Target?
The price target for ALT5 Sigma over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ALTS A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ALT5 Sigma is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ALTS?
You can purchase shares of ALT5 Sigma via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ALT5 Sigma shares.
-
What Is The ALT5 Sigma Share Price Today?
ALT5 Sigma was last trading at $6.68 per share. This represents the most recent stock quote for ALT5 Sigma. Yesterday, ALT5 Sigma closed at $6.80 per share.
-
How To Buy ALT5 Sigma Stock Online?
In order to purchase ALT5 Sigma stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
70
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
99
SOC alert for May 20
Sable Offshore [SOC] is down 0.79% over the past day.
Buy
52
RGC alert for May 20
Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.
Sell
40
GWLIF alert for May 20
Great-West Lifeco [GWLIF] is up 13.42% over the past day.
